In early 2011, the Centers for Disease Control and Prevention (CDC) sent a team of disease detectives to Florida to assist the state and a healthcare facility stop an outbreak of carbapenem-resistant Enterobacteriaceae, deadly pathogens that cause healthcare-associated infections.
CRE are a concern in long-term acute care hospitals, where patients who need to be on life-support for long periods of time receive care. They are resistant to almost all drugs, difficult to treat, and are associated with high death rates (up to 40 percent in some studies).  Read about Floridas success in stopping the spread of this public health threat by clicking HERE.Â
Â
If you want even more details about this outbreak, read the scientific paper in the October issue of the journal Infection Control and Hospital Epidemiology.
Â
For more information about how your facility can stop CRE, see CDCs CRE toolkit: http://www.cdc.gov/HAI/organisms/cre/index.html Â
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.